Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
D000661:Amphetamine / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000601:surgery; D002090:Butyrophenones / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D004564:Electrocoagulation; D006220:Haloperidol / Q000494:pharmacology; D006652:Histological Techniques; D008297:Male; D006899:Mixed Function Oxygenases / Q000494:pharmacology; D009069:Movement Disorders; D009410:Nerve Degeneration; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000502:physiology; D011187:Posture; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012399:Rotation; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000187:drug effects; D009435:Synaptic Transmission; D013997:Time Factors
D002090:Butyrophenones; D012110:Reserpine; D000661:Amphetamine; D006899:Mixed Function Oxygenases; D006220:Haloperidol; D001058:Apomorphine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine